Electra Therapeutics, Inc. (ETRA) Form 10-Q Quarterly Reports
Electra Therapeutics, Inc. (ETRA) is a publicly traded company on the Nasdaq, categorized under SIC 2836 (Biological Products, (No Diagnostic Substances)). Access real-time SEC filings, 10-K annual reports, 10-Q quarterlies, 8-K current reports, PCAOB auditor history, and executive compensation disclosures.
Ticker: ETRA
CIK: 2088082
Exchange: Nasdaq
SIC 2836: Biological Products, (No Diagnostic Substances)
Fiscal Year End: 12/31
State: DE
Independent PCAOB Auditor
Explore PCAOB Audit Intelligence →
Audit Firm
Ernst & Young LLP
Auditor SinceSince 12/31/2025 12:00:00 AM
Lead Engagement PartnerIshpal Shahpuri
Audit LocationSan Mateo, California, United States
Latest SEC EDGAR Filings
Showing 10-K, 10-Q, 8-K, Form 4, and other SEC submissions| Form | Filing Date | Reporting Period | Description | Accession Number | Actions |
|---|---|---|---|---|---|
| SCHEDULE 13G | 2026-09-28 | — | SCHEDULE 13G Filing | 0001104659-26-111478 | View SEC Doc Filr Page |
| SCHEDULE 13G | 2026-09-28 | — | SCHEDULE 13G Filing | 0001193125-26-405752 | View SEC Doc Filr Page |
| SCHEDULE 13D | 2026-09-25 | — | SCHEDULE 13D Filing | 0000947871-26-000898 | View SEC Doc Filr Page |
| 4 | 2026-09-23 | 2026-09-21 | 4 Filing | 0000947871-26-000881 | View SEC Doc Filr Page |
| 4 | 2026-09-23 | 2026-09-21 | 4 Filing | 0000947871-26-000880 | View SEC Doc Filr Page |
| 3 | 2026-09-21 | 2026-09-21 | OWNERSHIP DOCUMENT | 0001104659-26-109399 | View SEC Doc Filr Page |
| 4 | 2026-09-21 | 2026-09-21 | 4 Filing | 0002153365-26-000004 | View SEC Doc Filr Page |
| 4 | 2026-09-21 | 2026-09-21 | 4 Filing | 0001817449-26-000009 | View SEC Doc Filr Page |
| 4 | 2026-09-21 | 2026-09-21 | 4 Filing | 0002153366-26-000006 | View SEC Doc Filr Page |
| 4 | 2026-09-21 | 2026-09-21 | 4 Filing | 0002153364-26-000004 | View SEC Doc Filr Page |
| S-8 | 2026-09-21 | — | S-8 | 0001193125-26-396741 | View SEC Doc Filr Page |
| 8-K | 2026-09-21 | 2026-09-21 | 8-K | 0001193125-26-396646 | View SEC Doc Filr Page |
| 424B4 | 2026-09-18 | — | 424B4 | 0001193125-26-395670 | View SEC Doc Filr Page |
| 3 | 2026-09-18 | 2026-09-18 | 3 Filing | 0000947871-26-000874 | View SEC Doc Filr Page |
| 3 | 2026-09-18 | 2026-09-18 | 3 Filing | 0002153761-26-000002 | View SEC Doc Filr Page |
| 3 | 2026-09-18 | 2026-09-18 | 3 Filing | 0001397266-26-000004 | View SEC Doc Filr Page |
| 3 | 2026-09-18 | 2026-09-18 | 3 Filing | 0002153198-26-000002 | View SEC Doc Filr Page |
| 3 | 2026-09-18 | 2026-09-18 | 3 Filing | 0002153366-26-000004 | View SEC Doc Filr Page |
| 3 | 2026-09-18 | 2026-09-18 | 3 Filing | 0002153366-26-000003 | View SEC Doc Filr Page |
| 3 | 2026-09-18 | 2026-09-18 | 3 Filing | 0002153365-26-000002 | View SEC Doc Filr Page |
| 3 | 2026-09-18 | 2026-09-18 | 3 Filing | 0001282930-26-000012 | View SEC Doc Filr Page |
| 3 | 2026-09-18 | 2026-09-18 | 3 Filing | 0002153768-26-000002 | View SEC Doc Filr Page |
| 3 | 2026-09-18 | 2026-09-18 | 3 Filing | 0001817449-26-000007 | View SEC Doc Filr Page |
| 3 | 2026-09-18 | 2026-09-18 | 3 Filing | 0002153364-26-000002 | View SEC Doc Filr Page |
| CERT | 2026-09-18 | — | CERT Filing | 0001354457-26-000887 | View SEC Doc Filr Page |